Life sciences SPAC HighCape Capital Acquisition II files for a $200 million IPO

HighCape Capital Acquisition II, the second blank check company formed by HighCape Capital targeting life sciences, filed on Wednesday with the SEC to raise up to $200 million in an initial public offering.

The New York, NY-based company plans to raise $200 million by offering 2Read More